MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic Function
MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic Function
Not yet recruiting · NCT03606538 · Registry updated 2024-10-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic Function | Hepatic Impairment; Pharmacokinetics | Not yet recruiting | Phase 1 | 2024-10-30 | NCT03606538 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Resilient Pharmaceuticals | 4 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Alliance for Multispecialty Research, LLC. | Knoxville | United States | 1 |